Parabolic Drugs Ltd. - Research Center
533211 PARABDRUGS Group (Z) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 20 |
Sep ' 18 |
Sep ' 17 |
Sep ' 16 |
Mar ' 16 |
Sales |
- |
17.82 |
39.99 |
27.56 |
34.11 |
Operating profit |
-2.15 |
-10.80 |
-8.40 |
-31.91 |
-213.78 |
Interest |
0.63 |
3.95 |
4.36 |
60.21 |
55.37 |
Gross profit |
-2.51 |
-13.96 |
-8.64 |
-92.12 |
-269.15 |
EPS (Rs) |
-2.05 |
-4.02 |
-4.34 |
-19.46 |
-49.52 |
Half yearly
results in details
|
Sep ' 20 |
Sep ' 18 |
Sep ' 17 |
Sep ' 16 |
Mar ' 16 |
Other income |
0.27 |
0.79 |
4.12 |
- |
- |
Stock adjustment |
- |
4.67 |
-0.91 |
25.17 |
184.00 |
Raw material |
- |
14.88 |
35.55 |
22.14 |
28.04 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.84 |
2.86 |
4.83 |
3.70 |
5.03 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
1.31 |
6.21 |
8.92 |
8.46 |
30.82 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
10.19 |
11.40 |
17.30 |
26.77 |
32.90 |
Taxation |
- |
-0.48 |
0.90 |
1.54 |
4.43 |
Net profit / loss |
-12.70 |
-24.88 |
-26.84 |
-120.43 |
-306.48 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
61.89 |
61.89 |
61.89 |
61.89 |
61.89 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
379.75 |
379.75 |
Agg.of non promotoholding (%) |
- |
- |
- |
61.36 |
61.36 |
OPM (%) |
- |
-60.61 |
-21.01 |
-115.78 |
-626.74 |
GPM (%) |
- |
-75.01 |
-19.59 |
- |
- |
NPM (%) |
- |
-133.69 |
-60.85 |
- |
- |